Get started
BASILEA NBB

BASILEA N

44.75CHFD
−0.20−0.44%
As of today at 15:30 GMT
CHF
No trades
See on Supercharts
Overview
Financials
News Ideas Discussions Technicals Forecast Seasonals

BSLN fundamentals

Key facts

Market capitalization‪547.13 M‬CHF
Dividend yield (indicated)—
Price to earnings Ratio (TTM)7.72
Basic EPS (TTM)6.40CHF
Founded2000
Employees (FY)164
CEODavid Veitch
Websitebasilea.com
About

Basilea Pharmaceutica AG engages in the development and commercialization of pharmaceutical products. Its products include antifungals and antibiotics. The company was founded on October 17, 2000, and is headquartered in Allschwil, Switzerland.

Ownership
‪‪12.27 M‬‬
Free Float shares
‪‪11.25 M‬‬ (91.71%)
Closely held shares
‪‪1.02 M‬‬ (8.29%)
Free Float shares
‪‪11.25 M‬‬ (91.71%)
Closely held shares
‪‪1.02 M‬‬ (8.29%)
Capital structure
Market cap
‪‪547.13 M‬‬
Debt
‪‪111.67 M‬‬
Cash & equivalents
‪‪124.56 M‬‬
Enterprise value
‪‪534.24 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪547.13 M‬‬
Price to earning ratio (P/E)
7.72x
Price to sales ratio (P/S)
2.99x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
7.72x
Price to sales ratio (P/S)
2.99x
Valuation ratios
‪0.00‬
‪1.00‬
‪2.00‬
‪3.00‬
‪4.00‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪0.00‬
‪17.00‬
‪34.00‬
‪51.00‬
‪68.00‬
P/E
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−50%‬
‪−25%‬
‪0%‬
‪25%‬
‪50%‬
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−50.00 M‬‬
‪0.00‬
‪‪50.00 M‬‬
‪‪100.00 M‬‬
‪‪150.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪0.00‬
‪‪35.00 M‬‬
‪‪70.00 M‬‬
‪‪105.00 M‬‬
‪‪140.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪0.00‬
‪‪35.00 M‬‬
‪‪70.00 M‬‬
‪‪105.00 M‬‬
‪‪140.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Innovative Pharmaceutical Products
By country
Period: 2024
Ireland
Japan
United States
Uruguay
Canada
United Kingdom
Jordan
Sweden
China
Other

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
‪0.00‬
‪‪35.00 M‬‬
‪‪70.00 M‬‬
‪‪105.00 M‬‬
‪‪140.00 M‬‬
Actual
Estimate
Earnings
Next:Aug 19, 2025
H1 '23
H2 '23
H1 '24
H2 '24
H1 '25
‪−2.10‬
‪0.00‬
‪2.10‬
‪4.20‬
‪6.30‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

No dividends
BSLN has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company

Debt level and coverage
H2 '22
H1 '23
H2 '23
H1 '24
H2 '24
‪‪−70.00 M‬‬
‪0.00‬
‪‪70.00 M‬‬
‪‪140.00 M‬‬
‪‪210.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪60.00 M‬‬
‪‪120.00 M‬‬
‪‪180.00 M‬‬
‪‪240.00 M‬‬
Assets
Liabilities